DDR on DTC: Reclast

Share this article:
DDR on DTC: Reclast
DDR on DTC: Reclast
An implicit objective of all DTC campaigns is to empower patients with information to speak to their HCP about a treatment or specific drug. Novartis has taken this notion a step further by actually demonstrating this in its new campaign for osteoporosis drug Reclast.
Reclast is a once-a-year infusion treatment, which creates a challenge for marketers trying to build “loyal” customers. However, the Reclast team and its agencies have introduced a proactive group of brand spokespeople to leverage information about the “Reclast experience.” On the website, we literally see a “coffee klatch” of women talking about their concerns with the drug and how they overcame them. It is not hard-hitting, but the conversation makes it very persuasive. The print ad is particularly effective because it conveys immediacy as well as an old-fashioned “down-to-earth” flavor via its use of a simple Courier typeface. In this campaign, after the testimonies of the patients, the typeface itself is the star—conveying emotion and signaling “something old/something new” to a target of 60+ year olds with whom it will resonate.
The women we see in this campaign look very much like the drug's target audience, and with their “real” conversation and quotes in the print ad, they share genuine comments and concerns. Conveniently, the ad body copy answers these issues point-by point in easy-to-understand language.
You could say these women have been empowered to treat osteoporosis. And you would be right.

Deborah Dick-Rath is SVP, healthcare, at Symphony Advanced Media. Contact: deborahdrath@optonline.net
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?